Abivax Sa
Officers & Directors
Marc de Garidel, age 68, has served as Chief Executive Officer and Director since May 5, 2023. He has over 40 years of experience in the pharmaceutical and biotechnology sectors, including CEO positions at CinCor Pharma, AZTherapies, Corvidia Therapeutics, and Ipsen. His educational background includes degrees in Civil Engineering, International Management, and an executive MBA. Didier Blondel, age 63, has been Executive Vice President, Chief Financial Officer, and Board Secretary since January 2017. He previously served as CFO at Sanofi Pasteur MSD and held senior finance roles at Sanofi. He holds a Master's degree in Business and Administration, a Master's in Finance and Accounting, and a Graduate Diploma in Finance and Accounting. Fabio Cataldi, age 59, has been Chief Medical Officer since July 2024, bringing over 20 years of experience in the development and commercialization of innovative therapies, along with extensive clinical, medical, and scientific expertise.
Abivax Sa currently has 11 employees.
|
